(Q44205516)

30 November 2017

The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial (English)

1 reference

30 November 2017

0 references

Stefan Störk

1

1 reference

PubMed ID

12417281

30 November 2017

Clemens von Schacky

series ordinal

2

1 reference

PubMed ID

12417281

30 November 2017

Peter Angerer

series ordinal

3

1 reference

30 November 2017

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

165

1 reference

30 November 2017

2

1 reference

30 November 2017

301-307

1 reference

Hormone replacement therapy, heart disease, and other considerations

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Coronary heart disease in women--an ounce of prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Clinical practice. Postmenopausal hormone-replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Changing concepts of atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Hormone replacement therapy, inflammation, and hemostasis in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Hormone replacement therapy and increased plasma concentration of C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Vascular effects of estrogen and vitamin E therapies in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900242-3

10.1016/S0021-9150(02)00242-3

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12417281